Meunier P, Rochas A, Lambert R
Gut. 1979 Dec;20(12):1095-101. doi: 10.1136/gut.20.12.1095.
Manometric studies of the sigmoid colon were performed on 17 healthy volunteers and on 49 constipated patients, after a long period of fasting (18--20 hours). Motility was recorded using perfused catheters at basal level during 45 minutes, then 60 minutes after a 0.5 mg intravenous injection of neostigmine, and, finally, 30 minutes during and after a meal. Motor activity was assessed by a motility index (per cent of activity x mean amplitude of waves). In both normal and constipated patients, the basal motility index was very low (respectively 82 +/- 16 and 110 +/- 113). This low level of activity was due to the long fasting period imposed on all the subjects. After neostigmine the motility index increased in both controls (347 +/- 256) and constipated patients (311 +/- 325); this test, however was found to be unreliable. The meal increased the motility index to significantly higher values than after neostigmine in controls (538 +/- 215). In constipated patients the mean meal motility index was comparable with that of controls (577 +/- 549) with a large distribution of individual values. Using the mean meal motility index +/- 2 SD of the control group as a term of comparison, the patients were segregated into three groups: 'hypomotor' patients (eight cases), 'normomotor' patients (33 cases), and 'hypermotor' patients (eight cases). From the evidence of this series of clinically well-defined constipated patients, it was concluded that only the meal test is able to segregate three significant patterns of sigmoid activity and that a large number (68%) of constipated patients exhibit normal sigmoid motor activity.
在17名健康志愿者和49名便秘患者经过长时间禁食(18 - 20小时)后,对其乙状结肠进行了测压研究。在基础水平下,使用灌注导管记录45分钟的运动情况,然后在静脉注射0.5毫克新斯的明后60分钟记录,最后在进餐期间及进餐后30分钟记录。通过运动指数(活动百分比×平均波幅)评估运动活性。在正常患者和便秘患者中,基础运动指数都非常低(分别为82±16和110±113)。这种低活性水平是由于对所有受试者施加了长时间禁食。新斯的明注射后,对照组(347±256)和便秘患者(311±325)的运动指数均升高;然而,发现该测试不可靠。进餐使对照组的运动指数升高到显著高于新斯的明注射后的水平(538±215)。在便秘患者中,进餐时的平均运动指数与对照组相当(577±549),个体值分布较广。以对照组进餐时平均运动指数±2标准差作为比较标准,将患者分为三组:“运动低下”患者(8例)、“运动正常”患者(33例)和“运动亢进”患者(8例)。从这一系列临床明确的便秘患者的证据来看,得出的结论是,只有进餐测试能够区分乙状结肠活动的三种显著模式,并且大量(68%)便秘患者表现出正常的乙状结肠运动活性。